Ospedale Fabrizio Spaziani

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Acute lymphoblastic leukaemia1 trial
• Acute myeloid leukaemia1 trial
• Atrial fibrillation1 trial
• Colorectal cancer1 trial
• Heart failure1 trial
• Stroke1 trial

Phase

• Phase 32 trials
• Phase 21 trial

Status

• Active, not recruiting1 trial
• Completed1 trial
• Recruiting1 trial
• Terminated1 trial

Lead sponsor

• Gruppo Italiano Malattie EMatologiche dell'Adulto2 trials
• Biotronik SE & Co. KG1 trial
• Fondazione GONO G.I.1 trial

Running trials

• Active, not recruiting

  Sequential Treatment With Ponatinib and Blinatumomab vs Chemotherapy and Imatinib in Newly Diagnosed Adult Ph+ ALL

  NCT04722848· Phase 3· Gruppo Italiano Malattie EMatologiche dell'Adulto· Source

• Recruiting

  Gemtuzumab Chemotherapy MRD Levels; Adult Untreated, de Novo, Fav Interm Risk AML

  NCT04168502· Phase 3· Gruppo Italiano Malattie EMatologiche dell'Adulto· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Acute myeloid leukaemia1 recruiting

Closed trials

• Completed

  Comparison of two strategies that use the same drugs but with inverted sequence for the treatment of patients with metastatic colorectal cancer who have failed in previous therapies.

  2024-513296-41-00· Phase 2· Fondazione GONO G.I.· Source

• Terminated

  Clinical Benefits of the Closed Loop Stimulation in Sinus Node Disease

  NCT02579889· Biotronik SE & Co. KG· Source